CLINICAL TRIALS PROFILE FOR TRANXENE
✉ Email this page to a colleague
All Clinical Trials for TRANXENE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00775996 ↗ | Bioequivalence Study of Clorazepate Dipotassium 15mg Tablets Under Fasting Conditions | Completed | Ranbaxy Laboratories Limited | N/A | 2003-08-01 | The objective of this study was to compare the single-dose relative bioavailability of Ranbaxy and Abbott (TranxeneeT-Tab®) 15 mg clorazepate dipotassium tablets under fasting conditions. |
NCT02323659 ↗ | Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas | Unknown status | Polish Lymphoma Research Group | Phase 4 | 2014-06-01 | Comparison of methotrexate versus interferon-alfa 2b on efficacy, safety and quality of life in patients with primary cutaneous T-cell lymphomas after failure of topical or phototherapy treatment. |
NCT04726592 ↗ | Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room | Recruiting | Assistance Publique - Hôpitaux de Paris | Phase 3 | 2021-07-08 | The purpose of this study is to evaluate the efficacy of clorazepate in addition to the usual medication for treating migraine attack in the emergency room |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TRANXENE
Condition Name
Clinical Trial Locations for TRANXENE
Trials by Country
Clinical Trial Progress for TRANXENE
Clinical Trial Phase
Clinical Trial Sponsors for TRANXENE
Sponsor Name